Alnylam Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 6,672 | 0.00528% |
State or Government | 86,697 | 0.0686% |
Individual Insiders | 444,501 | 0.352% |
General Public | 7,251,949 | 5.73% |
Institutions | 118,662,280 | 93.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
23,049,248 | R$16.9b | 1.33% | 0.17% | |||
11,943,895 | R$8.8b | 2.46% | 0.03% | |||
10,064,110 | R$7.4b | -9.03% | 0.1% | |||
8,521,115 | R$6.2b | 1.53% | 0.02% | |||
7,214,198 | R$5.3b | 12.2% | 0.16% | |||
6,967,097 | R$5.1b | -14.7% | 0.43% | |||
6,910,032 | R$5.1b | -5.65% | 0.09% | |||
3,674,310 | R$2.7b | -1.94% | 0.24% | |||
3,118,552 | R$2.3b | 7.55% | 0.02% | |||
2,734,230 | R$2.0b | -3.98% | 0.05% | |||
2,039,798 | R$1.5b | 101% | 0.03% | |||
1,926,736 | R$1.4b | 4.74% | 0.02% | |||
1,640,559 | R$1.2b | -2.54% | 4.18% | |||
1,111,111 | R$814.5m | 9.89% | 2.34% | |||
930,939 | R$682.4m | 17.1% | 0.03% | |||
885,585 | R$649.2m | 12% | 0.09% | |||
885,318 | R$649.0m | -1.01% | 1.44% | |||
831,534 | R$609.6m | -1.52% | 0.02% | |||
789,937 | R$579.1m | -4.65% | 0.02% | |||
764,520 | R$560.4m | -4.16% | 0.02% | |||
711,692 | R$521.7m | 15.8% | 0.02% | |||
608,728 | R$446.2m | -2.67% | 0.12% | |||
587,045 | R$430.3m | -1.33% | 1.09% | |||
543,411 | R$398.3m | 0.79% | 0.02% | |||
538,749 | R$394.9m | -43.3% | 0.01% |